What's happening
This bill prohibits insurance companies from charging fees or co-pays for one follow-up visit to refill an opioid prescription after an initial short-term prescription.
Why it matters
Reduces financial barriers for patients needing ongoing pain management. by ensuring that one follow-up appointment for refilling short-term opioid prescriptions does not incur out-of-pocket costs, which may help prevent abrupt discontinuation of necessary medication.
Targets a specific gap in opioid prescribing practices. many initial opioid prescriptions are limited to seven days or less, so this ensures patients with legitimate, continuing pain needs can access a timely refill without extra insurance charges.
May decrease the incentive for doctors to over-prescribe opioids at the initial visit. since patients won’t face extra costs for returning if additional medication is actually needed, potentially supporting safer prescribing patterns.
Limits the scope to just one follow-up visit per initial prescription. , balancing patient access to pain relief with ongoing oversight and insurance cost containment.
Albany, before your first meeting.
Every bill that moved yesterday, summarized in a sentence and ranked by impact. The Albany Scorecard follows on Sundays.
Free. Unsubscribe in one click. Want alerts on specific bills? Create an account.
Who cares
Patients prescribed opioids for seven days or less
The bill would bar fees, copays, coinsurance, deductibles or other conditions for one follow-up visit or refill when a follow-up appointment is required to obtain an additional opioid prescription or refill.
Insurers offering policies covered by Insurance Law section 3216
Policies covering opioid prescriptions would have to waive those charges and conditions for the qualifying visit or refill.
Physicians treating patients with pain
The bill would remove those insurance charges and conditions for a qualifying follow-up appointment, while allowing practitioners to issue appropriate renewals, refills or new prescriptions at subsequent consultations for the same pain.
Headline styles
No Co-Pays for Opioid Refills
Plain English, a few words. Used as the page title.
Sponsors
1 Co-sponsor
History
- Referred to insurance
- Referred to insurance
Companion bill
The same bill in the other chamber. A bill becomes law when one version passes both houses and the governor signs it, so either number can carry it.
End Opioid Refill Co-Pays
In Assembly Committee · Insurance · Sponsor Joe DeStefano
Full text
1 pageUnderlined is new[Struck] is removedOfficial text on nysenate.gov ↗
STATE OF NEW YORK
790
2023-2024 Regular Sessions
IN SENATE
January 6, 2023
Introduced by Sen. ORTT -- read twice and ordered printed, and when printed to be committed to the Committee on Insurance
AN ACT to amend the insurance law, in relation to prohibiting insurance companies from imposing a co-pay pursuant to a follow up visit with a physician in order to receive a refill on an opioid drug prescription
The People of the State of New York, represented in Senate and Assembly, do enact as follows:
Section 1. Subsection (i) of section 3216 of the insurance law is amended by adding a new paragraph 39 to read as follows:
(39) Every policy which provides coverage for opioid drug prescriptions shall not impose any fee, co-payment, co-insurance, deductible or other condition on any insured who requires a follow up appointment to receive an additional opioid drug prescription or a refill of an opioid drug prescription after an initial prescription for such opioid drug prescription which was written for a period of seven days or less. Such prohibition on any fee, co-payment, co-insurance, deductible or other condition is limited to one visit or one refill after the initial appointment or prescription. Upon any subsequent consultation for the same pain, the practitioner may issue, in accordance with this subsection, any appropriate renewal, refill, or new prescription for the opioid or any other drug.
§ 2. This act shall take effect on the ninetieth day after it shall have become a law.
EXPLANATION--Matter in italics (underscored) is new; matter in brackets
[ ] is old law to be omitted.
LBD03588-01-3
Reflowed for reading: line numbers and page breaks removed. Cite the official text.
Sponsor's memo
Title of bill
An act to amend the insurance law, in relation to prohibiting insurance companies from imposing a co-pay pursuant to a follow up visit with a physician in order to receive a refill on an opioid drug prescription
Purpose
To allow physicians to prescribe short term opioid prescriptions of 7 days or less to patients without fear that the patient would be forced to pay another co-pay for the medication and follow up visit.
Justification
New York State has a documented and serious problem with opioid abuse. Physicians currently may over prescribe opioids to patients for up to 30 days at a time because they fear the patient may not have the financial resources to pay more co-pays for follow up visits and for more medica- tion. Often these unnecessary pills are then abused by the patient or may sit in a medicine cabinet and can be abused by other members of that household.
This legislation will allow flexibility to a physician to prescribe the proper amount of opioids to patients without fear that it will be a financial burden to the patient should they need another short prescription. This will also reduce the amount of unused opioids that may then be abused.
Prior legislative history
S.3497 of 2021/2022; Referred to Insurance
S.279 of 2019/2020; Referred to Insurance
S.3666 of 2017/2018 Referred to Insurance
A.10435 of 2015/16 - Referred to insurance
Fiscal implications
None to the State.
Effective date
This act shall take effect on the nineteenth day after it shall have become a law.
Summaries, headlines and scores are AI-generated from the official bill text. How we score bills. Source: NYS Open Legislation.